The Official Journal of EuroPCR and the European Association of Percutaneous Coronary Interventions (EAPCI)
Showing 1-9 of 9 articles
Predictors of long-term adverse events after Absorb bioresorbable vascular scaffold implantation: a 1,933-patient pooled analysis from international registries
Caixeta A,
Campos C,
Felix C,
Chieffo A,
Capranzano P,
Kawamoto H,
Tamburino C,
Diletti R,
Costa Jr J,
Onuma Y,
van Geuns R,
Bartorelli A,
Colombo A,
Tamburino C,
Serruys P,
Abizaid A
September 20, 2019 | 10.4244/EIJ-D-16-00796
One-year clinical outcomes of patients treated with everolimus-eluting bioresorbable vascular scaffolds versus everolimus-eluting metallic stents: a propensity score comparison of patients enrolled in the ABSORB EXTEND and SPIRIT trials
Costa Jr J,
Abizaid A,
Bartorelli A,
Whitbourn R,
Jepson N,
Perin M,
Steinwender C,
Stuteville M,
Ediebah D,
Sudhir K,
Serruys P
November 20, 2016 | 10.4244/EIJV12I10A206
Impact of post-dilation on the acute and one-year clinical outcomes of a large cohort of patients treated solely with the Absorb Bioresorbable Vascular Scaffold
Costa Jr J,
Abizaid A,
Bartorelli A,
Whitbourn R,
van Geuns R,
Chevalier B,
Perin M,
Seth A,
Botelho R,
Serruys P
June 19, 2015 | 10.4244/EIJY15M05_06
First-in-man assessment of the InSeal VCD, a novel closure device for large puncture accesses
April 20, 2015 | 10.4244/EIJV10I12A242
The ABSORB EXTEND study: preliminary report of the twelve-month clinical outcomes in the first 512 patients enrolled
Abizaid A,
Costa Jr J,
Bartorelli A,
Whitbourn R,
van Geuns R,
Chevalier B,
Patel T,
Seth A,
Stuteville M,
Dorange C,
Cheong W-F,
Sudhir K,
Serruys P
April 20, 2015 | 10.4244/EIJV10I12A243
Serial greyscale and radiofrequency intravascular ultrasound assessment of plaque modification and vessel geometry at proximal and distal edges of bare metal and first-generation drug-eluting stents
Costa Jr J,
Abizaid A,
Sousa A,
Siqueira D,
Chamié D,
Feres F,
Costa R,
Staico R,
Maldonado G,
Centemero M,
Tanajura L,
Viana R,
Chaves Á,
Abizaid An,
Sousa J
June 27, 2012 | 10.4244/EIJV8I2A36
Angiographic and intravascular ultrasound findings following implantation of the Endeavor™ zotarolimus-eluting stents in patients from the real-world clinical practice
Feres R,
Andrade P,
Costa R,
Costa Jr J,
Abizaid A,
Staico R,
Tanajura L,
Siqueira D,
Maia J,
Lasave L,
Sousa A,
Sousa J
August 14, 2009
Latest news
AHEAD OF PRINT
Extracardiac basal annuloplasty for the treatment of secondary mitral regurgitation
FREE ARTICLE - Jérémy Bernard et al
August 11, 2022
AHEAD OF PRINT
LVOT calcification in TAVI : a post hoc analysis from the SOLVE-TAVI trial
FREE ARTICLE - Serdar Farhan et al
August 9, 2022
NEW ISSUE
The 16th EBC Expert consensus; ticagrelor or aspirin monotherapy 1 year after PCI; vasospasm and atherosclerosis in ANOCA; lifetime valve journey; and more…
August 5, 2022
AHEAD OF PRINT
RADIANCE-HTN SOLO 36-month analysis
FREE ARTICLE - Florian Rader et al
August 1, 2022
AHEAD OF PRINT
Percutaneous left atrial appendage closure with superior vascular access
FREE ARTICLE - Roberto Galea et al
August 4, 2022
AHEAD OF PRINT
Dual ProGlide vs ProGlide and FemoSeal after TAVI
FREE ARTICLE - Jonas M.D. Gmeiner et al
July 29, 2022
AHEAD OF PRINT
Stent thrombosis in comatose OHCA (ST-OHCA Study)
FREE ARTICLE - Martin Rauber et al
July 25, 2022